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Win 17,665 [topterone, (17p)-17-hydroxy-17-propylan-
drost-4-en-3-one] inhibited stimulation of flank organ 
development of castrated immature male hamsters by 
both testosterone and dihydrotestosterone, whereas pro-
gesterone inhibited the stimulation by only testosterone. 
Topical application of Win 17,665 on the flank organs of 
the male hamster did not cause any significant effect on 
testosterone metabolism of this tissue. In addition, there 
was no decrease in the lipogenic capacity of the flank 
organ. The evidence presented indicates that Win 17,665 
exerts its antiandrogenic action by binding with the 
cytosolic androgen receptor(s) in the flank organ thus 
inhibiting the action of dihydrotestosterone. 
The flank organ of the hamster is an androgen dependent 
sebaceous gland complex. Topical application of Win 17,665 
[ topterone, ( 17 [J) -17- hydroxy -17 -propylandrost-4 -en-3-on e ] 
has been shown to cause a regression in the development of the 
flank organ (2]. In the present investigation, we have studied 
the binding affmity of this antiandrogen to the cytosolic recep-
tor(s) as well as some of its specific effects on metabolism in 
sebaceous glands. 
MATERIALS AND METHODS 
Chemicals 
All radioactive chemicals were purchased from New England Nuclear 
Corp., Win 17,665 was synthesized in our chemistry division. 
Flanh Organ Medication and Evaluation 
Male Syrian golden hamsters were medicated topically on the fla nk 
organs with either ethanol ve~icle (5 p.l) or with Win 17,665 dissolved 
in vehicle for the period indicated . The hair on the flank organ was 
clipped 3 times a week during the medication period. On the day 
fo llowing the last t reatment, the animals were given an overdose of 
sodium pentobarbital. Evaluation of flank organ parameters was con-
ducted as previously descri bed [2]. Briefly, flank organ development 
was subjectively scored on the basis of degree of pigmentation, coarse-
ness of hair stubble, area and elevat ion graded from 0 for barely 
discernible to 4 for maximum development. The transverse diameter of 
the flank organ was measured in situ with vernier calipers. Weight was 
taken after excision of the flank organ around the periphery of the 
pigmented area. Cholesterol was then determined on an alkaline digest 
of the excised flank organ by a modification of the Liebermann-Bur-
chard procedure [3]. 
Measurement of Testosterone Conversion 
Testosterone metabolism was determined using the method of San-
sone and Reisner [4]. Flank organs were removed at sacrifice, stripped 
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of subcutaneous t issue, excised around the perimeter of the pigmented 
area a nd minced on ice. The incubation mixture containing testoster-
one-1,2-"H , 600 pmoles, 10p.Ci; penicillin G, potassium salt, 0.8 mg; 
streptomycin, 1 mg; glucose, llf-Lmoles; Tween 40 (1:50) 2 1-'1; a nd about 
50 mg of tissue mince in a final volume of 2.0 ml Krebs-Ringer 
phosphate buffer, pH 7.4 was incubated 5 hr at 37°C. The t issue was 
homogenized using a Polytron ST -20 and lipids were extracted with 
CHCb :MeOH (2:1). After filtration the CHCb layer was separated a nd 
evaporated to dryness under N 2 • The residue was taken up in CHCb 
and separated by thin-layer chromatography (TLC) on silica-gel plates. 
Plates were developed 3 times, with drying in between, in CHCb:MeOH 
(98.25: 1.75) and scanned for radioactive spots on a Vanguard TLC plate 
scanner equipped with a digital integrator. Authentic steroids were co-
chromatographed with tissue extracts in 2 different solvent systems in 
order to locate various metabolites of testosterone. Visualization of 
steroids on thin-layer plates was by ultraviolet light and iodine vapor. 
Counting gas-liquid chromatographic peaks of aut hentic steroids and 
relating the percentage composit ion formed to that obtained by TLC 
corroborated the thin layer findings. 
Binding S tudies with Tritiated Dihydrotestosterone eH-DHT) 
Sebaceous glands from male hamsters (110- 140 gm initially), cas-
trated t he previous day, were separated from the dermis and muscle 
layer by dissection of the flank organs on ice under a stereomicroscope. 
The t issue, consisting of the pilosebaceous unit containing some at-
tached epidermis, was minced and homogenized in 2 vol of buffer (50 
mM Tris, 0.5 mM mercaptoethanol and 0.1 mM EDTA, pH 7.4) in an 
all-glass homogenizer at 0°C. The homogenate was centrifuged at 
180,000 g for the preparation of cytosol. The protein content was 8-12 
mg/ ml, as determined by the Lowry method [5]. Steroid dilutions were 
made in buffer containing 0.5% bovine serum albumin (Fraction V) to 
prevent binding of trace quantities of steroids to pipets or tubes. One 
hundred p.l of cytosol was incubated with "H-DHT (190 Ci/m mole) 
with or without unlabeled DHT or Win 17,665 according to the proce-
dure of Shain a nd Boesel [6,7]. After incubating the cytosol preparation 
for 2 hr at 0°C, 50 p.l of a dextran and gamma globulin-coated charcoal 
mixture (2.5% charcoal, 0.25% dextran T-70 and 0.5% gamma gl0bulin 
in the above buffer) was added followed 10 min later by 12.5p.l absolu te 
etha nol. After cent rifugation at 24,000 g, 100 p.l of supernatant was 
counted. 
Lipogenic Activity 
Lipogenesis was determined by measuring the incorporation of 14C-
acetate into flank organ lipids according to t he procedure of Lutsky, 
Koziol, and Gershaw [8]. After the t reatment period, the flank organs 
were depilated and removed following sacrifice of the animals. Flank 
organs from control hamsters were used singly whereas 2 smaller Win 
17,665-treated flank organs were combined for each determination. The 
left flank organs used for this analysis were minced, weighed and 
incubated in Krebs-Ringer phosphate buffer pH 7.4 fortified with 5 mM 
glucose and 43 p.M sodium lYC acetate (58 mCi/mmole) and protected 
from bacterial metabolism by 5 mg% each of penicillin G, potassium 
salt, and streptomycin. After 3 hr at 37°C the flank organs were rinsed 
in fresh buffer and digested in 4% sodium hydroxide, acidified, extracted 
twice with hexane, and the amount of radioactive lipid formed was 
measured on a liquid scintillation counter. 
DNA was determined on the alkaline digest of the right flank organs 
by the method of Burton [9]. The digest was acidified with trichloro-
acetic acid, chilled, centrifuged a nd washed with ethanol. The DNA 
was solubilized at 80° with 1 N perchloric acid a nd color developed with 
the diphenylamine reagent. 
3-Hydroxy-3-methylglu taryl coenzyme A reductase (HMG CoA re-
ductase) was measured on flank organ microsomal pellets by the 
spectrophotometric procedure of Hulcher and Oleson [10). Free coen-
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zyme A formed in the reduction of HMG CoA to mevalonate was 
complexed with 5,5'-dithio-bis(2-nitrobenzoic acid) and measured at 
412 nm. 
RESULTS 
Comparison of Win 17,665 With Progesterone as Antagonists 
of Testosterone Propionate or Dihydrotestosterone (DHT) 
Both flank organs of immature castrated male hamsters 
(mean initial body weight, 59 gm) were treated with either 200 
p.g of Win 17,665 or 200 p.g of progesterone in conjunction with 
one of the above androgens and, following 2 weeks of daily 
treatment, flank organ parameters were evaluated. Progester-
one and Win 17,665 both had topical antiandrogenic activity on 
the hamster flank organ (Table 1). Win 17,665 inhibited the 
stimulation of flank organ parameters produced by both testos-
lerone propionate and DHT, whereas progesterone was only 
effective against testosterone propionate. 
Effect on Testosterone Metabolism 
Win 17,665 was tested as an inhibitor of the enzyme steroid 
Sa-reductase in vitro using the amount ofDHT-'1H formed from 
testosterone-aH by flank organ tissue minces as a measurement 
of activity. Win 17,665 inhibited this enzyme by 100±0, 53±6 
and 9±7% (Means ± SE) at 10- 2 , w-:] and w-• M, respectively, 
in 3 replicated experiments. When the parallel dose response 
lines for progesterone and Win 17,665 were compared, proges-
terone was approximately 10 times more inhibitory of Sa-re-
ductase in vitro than was Win 17,665. 
The effect of Win 17,665 treatment of hamster flank organs 
on testosterone metabolism in vitro and in vivo was also tested. 
Both flank organs of male hamsters (mean initial body weight, 
110 gm) were medicated for 3 weeks with 200 p.g of Win 17,665 
in 5 fll ethanol or with ethanol alone. The flank organs were 
removed 20 hr after the last treatment and analyzed to deter-
mine whether or not Win 17,665 caused a decrease in 5a-
TABLE I. Comparative effect s of topically applied Win 17,665 and 
progesterone as antagonists of testosterone propionate (TP) or 5a-
dihydrotestosterone (DHT) on {lan/1 organs of castrated hamsters 
Flank organ parameters 
Topica l treatment" per na nk 
Diameter'' Weight" Choleste rol'' Develop-organ for 14 days ment' ' (mm) (mg) (J.Lg) Score 
None 2.60 2.9 21 0 
±0.11 ±0.3 ±1 (0) 
1 p.gTP" 4.25 19.1 147 2.5 
±.09 ±l.O ±8 (2-3) 
I p.gTP" 3.52" 14.8' 103" 1.0" 
+ 200 J.Lg progesterone ±.12 ±1.0 ±3 (1-2) 
1 J.Lg TP" 2.91" 10.5" 77" 0.5" 
+ 200 p.g Win 17,665 ±.12 ±.8 ±6 (0-1) 
111g DHT 4.27 22.5 162 3.0 
±0.05 ±.9 ±6 (3-4) 
1 J.Lg DHT 4.20 20.4 136'' 3.0 
+ 200 p.g progesterone ±0.14 ±1.1 ±9 (3) 
1 tJ.g DHT 2.84" 9.8" 80' .75" 
+ 200 tJ.g Win 17,665 ±0.09 ±1.9 ±5 (0-2) 
"N =8. 
''Mean± SE. 
,. Median scored between 0 for barely visible to 4 for maximum 
development. Range in parentheses. 
"Amount indicated as free base. 
,. P < .05; rp < .01; "P < .001 compared with the mean of the 
corresponding androgen-stimulated control group. 
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reductase level. The data in Table II show that the amount of 
DHT or total Sa-reduced metabolites was unaltered in treated 
flank organs when expressed per unit of tissue weight. Treated 
flank organs were smaller; therefore, the amount of metabolites 
was reduced. In a nother study, 5 flCi of 40 Ci/mmole '1H-
testosterone was applied directly to the flank organ in place of 
one of the daily treatments 3 weeks after being medicated each 
day with Win 17,665. Five hours later, flank organs were pooled 
and extracted for radioactive metabolites as before. Under these 
conditions, the in vivo conversion of "H-testosterone to aH-
DHT was 5.6 ± 0.77% and 5.7 ± 0.63% (Means ± SE for 7 
replications) in treated and control flank organs, respectively. 
Binding of Win 17,665 to the Cytosolic Receptor 
When flank organ cytosol was incubated with 2 nM 3H -DHT, 
22.4% of the total added 3H-DHT was bound to the receptor 
protein. With the addition of 20, 200 and 2000 nM Win 17,665 
to the incubation mixture, the total binding was reduced to 
15.8, 9.6 and 7.6%, respectively. Nonspecific binding; i.e., the 
binding of 3H -DHT in the presence of a thousandfold excess of 
unlabeled DHT, was 4.0% under the above conditions. A typical 
Scatchard plot is shown in the Figure. 
Cytosol was incubated with 0.2 to 2.5nM "H-DHT with or 
without a constant concentration \10 nM) of Win 17,665. Cor-
rection for nonspecific binding was made by adding an excess 
of DHT. The equilibrium dissociation constants, Ko, were 
determined according to Shain and Boesel [6,7]. From several 
such Scatchard plots, the following range of values was ob-
tained: Ko for DHT, 0.6-5 nM; Ko for Win 17,665, 3-10 nM; total 
number of binding sites for 100 mg cytosolic protein, 3-10 
pmoles. 
Win 17,665 appears to interfere with in vivo retention in the 
hamster flank organ ofradioactivity originating from "H-testos-
terone. Male hamsters (mean initial body weigh t, 120 gm) were 
medicated on the left flank organ with vehicle and on the right 
flank organ with Win 17,665 for 1 or 7 days. They were castrated 
one day prior to the labeled hormone injection. One hour after 
the final topical medication, each hamster was injected subcu-
taneously with 40 flCi of aH-testosterone (40 Ci/mmole) dis-
solved in 0.1 ml of 15% alcoholic saline. One hour later, each 
flank organ was removed, dried, burned in a Packard Tritium 
Oxidizer and the aH20 counted. The data in Table III were 
calculated to exclude nonspecific interactions of testosterone 
and its metabolites with skin tissue, leaving a net value reflect-
ing the amount associated with the sebaceous glands. The data 
TABLE II. Effect of Win 17,665 treatment on 3 H -testosterone 
metabolism in vitro 
Testosterone utilized 
pmoles/mg tissue 
pmoles/ fl ank organ 
DHT formed 
pmoles/ mg tissue 
pmoles/flank organ 
Total Sa-reduced products formed" 
pmoles/mg tissue 
pmoles/flank organ 
Topical Treatment per nank organ 
for 12 days (Mean ± SE)" 
Vehicle 
7.55 ± .19 
320 ± 18 
2.40 ± .15 
102 ± 9 
4.49 ± .4 
192 ± 22 
Win 17,665 
7.48 ± .23 
141 ± 5'' 
2.37 ± .13 
44 ± 1'' 
4.87 ± .18 
92 ± 5'' 
" Because the weights of flank organs in the vehicle control group 
were higher than those in the treated group, 4 flank organs from the 
control group were pooled and minced for each assay and 6 flank organs 
from the Win 17,665 treated hamsters were combined and minced for 
each assay. Each assay was replicated 6 times according to the proce-
dure given in the Materials and Methods section except that the glucose 
concentration was doubled and the total volume of incubation medium 
was halved. 
'' Total 5a-reduced products consisted of the sum of DHT, 5a-an-
drostanediol and 5a-androstanedione. 
,. P < .001 compared with the mean of the vehicle-treated group. 
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Scatchard plot of "H-DHT binding to the cytosol of hamster flank 
organs. The cytosol (10.5 mg protein/ml) was incubated with "H-DHT 
(0.2-2.5 nM) with and without 10 nM Win 17,665. 
TABLE III. Effect of Win 17,665 on the incorporation of 
radioactivity in the (lanll organs of mature male hamsters 
injected with 3H -testosterone 
Mean net Difference Flank Topical treatment N OPM / mg between 
means organ flank organ" DPM/ rng 
Left Vehicle 7 311 61 
Right Once with 50 1-'g 7 250 
Win 17,665 
Left Vehicle 7 240 96 
Right Once with 200 1-'g 7 144 
Win 17,665 
Left Vehicle 9 435 268 
Right Once daily for 7 9 167 
days with 200 1-'g 
Win 17,665 
SE mean 
difference 
±22" 
±22'. 
±41'( 
"Left and right flank organs and adjacent skin were analyzed for 
retained radioactivity 1 hr after s.c. injection of "H-testosterone. Re-
tained radioactivity in adjacent skin, having fewer sebaceous glands 
and therefore fewer androgen receptors, expressed as dpm/mg was 
subtracted from retained radioactivity in flank organs to give a net 
value. Statistical analysis was performed by comparing results from 
vehicle treated and Win 17,665 treated flank organ pairs from the same 
animal replicated over the number of hamsters indicated in the table. 
"P < 0.05; 'P < 0.01; <~p < 0.001. 
show that a single topical treatment with Win 17,665 reduced 
the incorporation of radioactive '1H-testosterone into the flank 
organ of the male hamster. This effect was dose-related. Treat-
ing flank organs for one week with Win 17,665 produced a 
greater effect. 
Effect on Lipogenic Activity 
Lipogenesis in the hamster flank organ has been shown to 
decrease with castration and increase with androgen stimula-
tion [8,11]. After confirming the above observations, the effect 
of Win 17,665 on the lipogenic capacity of the flank organ in 
groups of 12 intact, mature males was measured. Flank organ 
weights were decreased from 50 ± 1.9 mg in vehicle-treated 
control hamsters to 22 ± 0.9 mg (P < 0.001) by treatment with 
200 p.g of Win 17,665 for 3 weeks. This decrease in weight was 
due to a decrease in the number of cells, since the p.g DNA/ mg 
wet weight values in Table IV were the same for both groups. 
Treatment with Win 17,665 caused a doubling in the lipogenic 
capacity of the flank organ when expressed per unit weight or 
per amount of DNA. 
As illustrated in Table I, the cholesterol content of the 
hamster flank organ was increased by androgen application to 
castrates and antagonized by concurrent administration of Win 
17,665. Cholesterol is a major constituent of animal sebum [12] 
a nd of cell membranes which increase with androgen stimula-
tion. The activity of 3-hydroxy-3-methylglutaryl CoA reduc-
tase, considered the rate-limiting enzyme for cholesterol syn-
thesis, was measw·ed. The specific activity was higher in the 
flank organs of male hamsters treated with 200 p.g of Win 17,665 
for 4 weeks when compared to the flank organs of the vehicle-
treated control hamsters (7.0 ± 0.5 versus 4.0 ± 0.8 nmoles CoA 
formed/minute/rug microsomal protein). In this experiment, 
four flank organs were pooled for the preparation of each 
microsomal enzyme pellet and 5 microsomal preparations were 
run in each group. 
DISCUSSION 
DHT, considered the peripherally active androgen responsi-
ble for the enlargement of the flank organ, is formed from 
testosterone by the enzyme 5a-reductase. Some antiandrogens 
act by inhibiting this enzyme. Progesterone, which counteracts 
the stimulation caused by testosterone but not DHT in the 
castrated hamster flank organ, appears to be such an antian-
drogen. However, Win 17,665 is topically effective against both 
testosterone and DHT suggesting that Win 17,665 blocks the 
androgen receptor in the cytosol. 
In this report, we have provided evidence that Win 17,665 
competes with the binding of DHT to the androgen receptors 
in th e cytosol. The equilibrium dissociation constant of DHT 
obtained by us is comparable with that obtained in another 
laboratory [13]. The binding affinity of Win 17,665 is slightly 
less t han t hat of DHT. Although Win 17,665 is a weak inhibitor 
of the enzyme 5a-reductase in flank organ mince preparations, 
no sustained effect from topical application of Win 17,665 was 
noted on testosterone metabolism in vitro or in vivo. 
In our previous repm;t [2], we showed that the total lipid and 
t he total cholesterol of the flank organ of t he male hamster was 
decreased by treatment with Win 17,665. Lutsky, Koziol, and 
Gershaw [8] have demonstrated that the topical application of 
certain androgens stimulates lipogenesis in the flank organ of 
the female hamster as measured by the incorporation of labeled 
acetate into total lipids in vitro. However, there was a consid-
erable difference in androgen specificity; some androgens such 
as anchosterone were highly Lipogenic whereas DHT produced 
a much greater degree of tissue hypertrophy. Our results indi-
cate that topical treatment with the antiandrogen Win 17,665 
did not impair the lipogenic capacity of the flank organ tissue 
TABLE IV. Effect of Win 17,665 on the in vitro lipogenic rate of 
flanh organs in male hamsters 
Topical treat- Lipogenesis" pmoles '·'C-acetate 
ment per 11gDNA incorporated into lipids in 3 hr N flank organ mg wet wt Per flank or- per mg wet per 11g for 21 days gan wt DNA 
Vehicle 12 2.43 ± 0.03 2915 ± 424 59 ± 8 24 ± 3.6 
200 1-'g Win 12 2.42 ± 0.08 2804 ± 223 126 ± 10" 54± 4" 
l7,665 
"Means± SE of 12 separate determinations of sodium l- 14C-acetate 
incorporation into total lipids from flank organs receiving the described 
treatments. 
1
' P < 0.001 compared with the mean of the vehicle-treated control. 
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despite the previously shown reduction in the flank organ 
weight and sebaceous gland area [2]. 
The evidence indicates that the lipogenic capacity of the 
flank organ per unit DNA or wet weight was significantly 
increased in the Win 17,665-treated hamster. The specific activ-
ity of 3-hydroxy-3-methylglutaryl CoA reductase was also in-
creased which might partially explain the increased rate of 
lipogenesis. An increase in the specific activity of this enzyme 
may be a compensatory mechanism to regulate cholesterol 
biosynthesis in the smaller flank organ. 
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